FDA.reportPublic FDA data

Hepatitis B virus e-antigen total antibody IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of total antibodies to the Hepatitis B virus e-antigen in a clinical specimen.
GUDID devices
6
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
08056771103435LIAISON XL MUREX Control Anti-HBeDIASORIN SPA3181612021-04-13
00842768022685Atellica IM aHBe2 QCSiemens Healthcare Diagnostics Inc.107330222022-05-05
00630414167947ADVIA Centaur aHBe2 QC KITSiemens Healthcare Diagnostics Inc.107208322022-01-14
28056771103439LIAISON XL MUREX Control Anti-HBeDIASORIN SPA3181612021-04-13
00847661002611VIROTROLBIO-RAD LABORATORIES, INC.001112020-09-14
00816784020307ACCURUN®Lgc Clinical Diagnostics, Inc.2015-00722018-09-24